https://soundpharma.com/news/ 2026-07-14T15:37:36+00:00 https://soundpharma.com/the-world-health-organization-reports-1-1-billion-teens-and-young-adults-at-risk/ 2016-06-20T19:47:27+00:00 https://soundpharma.com/dod-hearing-center-of-excellence-establishes-guidance-on-temporary-and-permanent-hearing-loss-and-clinical-trials/ 2016-06-20T19:47:27+00:00 https://soundpharma.com/sound-pharmaceuticals-to-present-at-the-15th-annual-needham-company-healthcare-conference/ 2016-06-20T19:47:27+00:00 https://soundpharma.com/spi-completes-mid-stage-ph-ii-clinical-trial-in-noise-induced-hearing-loss/ 2016-06-20T19:47:27+00:00 https://soundpharma.com/spi-granted-patent-for-prevention-and-treatment-of-side-effects-of-chemotherapy/ 2016-06-20T19:47:28+00:00 https://soundpharma.com/sound-pharmas-otoprotection-and-regeneration-work-were-presented-at-the-office-of-naval-research-conference-on-noise-induced-hearing-loss-in-san-diego-ca-onr-commissioned-a-video-demonstrat/ 2016-06-20T19:47:28+00:00 https://soundpharma.com/spi-in-nature-medicines-sound-medicine-news-feature/ 2016-06-20T19:47:28+00:00 https://soundpharma.com/nobel-prize-winner-bruce-beutler-joins-sound-pharmaceuticals-scientific-advisory-board/ 2016-06-20T19:47:28+00:00 https://soundpharma.com/sound-pharmaceuticals-and-the-university-of-florida-begin-enrollment-on-a-phase-ii-study-with-spi-1005-to-prevent-and-treat-noise-induced-hearing-loss/ 2016-06-20T19:47:28+00:00 https://soundpharma.com/abc-news-highlights-hearing-loss-as-a-growing-trend-in-society-and-the-impact-of-using-earbuds-at-high-volume-watch-this-informative-video-with-lead-reporter-diane-sawyer/ 2016-06-20T19:47:28+00:00 https://soundpharma.com/noise-at-sporting-events-can-damage-hearing/ 2016-06-20T19:47:28+00:00 https://soundpharma.com/sound-pharmaceuticals-interviewed-by-mit-technology-review/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/uspto-issues-notice-of-allowance-for-novel-patent-on-hair-cell-regeneration-in-the-inner-ear/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/sound-pharmaceuticals-announces-the-successful-completion-of-its-phase-i-clinical-trial-for-spi-1005/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/la-times-article-on-otoprotection/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/neurotech-insights-newsletter-focuses-on-hearing-loss-and-current-r-d-efforts-of-spi-pg-14/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/venturewire-lifesciences-story-covers-sound-pharmas-start-of-ph-ii-clinical-trials-of-spi-1005-to-prevent-and-treat-noise-induced-hearing-loss/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/sound-pharmaceuticals-receives-additional-dod-funding-for-its-hearing-regeneration-product/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/new-drug-for-hearing-loss-enters-clinical-testing/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/fda-allows-phase-2-study-for-sound-pharmaceuticals-novel-drug-to-prevent-chemotherapy-induced-hearing-loss/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/spi-receives-office-of-naval-research-award-for-hearing-loss-research-and-development/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/sound-pharma-to-receive-3m-in-dod-funding-to-further-develop-our-hearing-regeneration-program/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/sound-pharma-receives-grants-from-the-irs-under-the-qualifying-therapeutic-discovery-project-program-created-by-the-patient-protection-and-affordable-care-act-of-2010/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/ucla-and-sound-pharmaceuticals-identify-a-key-hearing-regeneration-protein-in-the-human-inner-ear/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/sound-pharma-announces-a-new-otoprotection-clinical-trial-involving-personal-music-players/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/bioworld-insight-coverage-on-hearing-loss-rd/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/uf-researchers-to-evaluate-spi-1005-in-ipod-clinical-trial/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/spi-awarded-best-presentation-at-the-16th-annual-amsconamsus-meeting-for-its-clinical-otoprotection-work/ 2016-06-20T19:48:03+00:00 https://soundpharma.com/spi-phase-2-data-submission-honored-as-a-top-12-oral-presentation-at-the-aao-hns-annual-meeting/ 2016-06-27T23:25:35+00:00 https://soundpharma.com/sound-pharma-submits-scientific-paper-for-presentation-on-positive-spi-1005-phase-2-clinical-trial/ 2016-06-27T23:43:22+00:00 https://soundpharma.com/david-guyer-visionary-biotech-leader-joins-sound-pharmaceuticals-seattle/ 2016-06-27T23:44:38+00:00 https://soundpharma.com/sound-pharmaceuticals-announces-two-new-executive-hires-to-accelerate-its-menieres-drug-development-program/ 2017-06-30T02:14:55+00:00 https://soundpharma.com/sound-pharmaceuticals-and-dod-collaborate-on-new-hearing-loss-guidance/ 2017-06-30T02:14:58+00:00 https://soundpharma.com/sound-pharmaceuticals-announces-positive-phase-1b-results-and-the-start-of-a-phase-2b-clinical-trial-in-menieres-disease-2/ 2018-01-14T03:55:28+00:00 https://soundpharma.com/university-of-oxford-and-sound-pharmaceuticals-begin-phase-2-clinical-trial-on-novel-treatment-for-bipolar-disorder-2/ 2018-01-14T03:57:17+00:00 https://soundpharma.com/sound-pharmaceuticals-to-present-preliminary-data-on-ototoxicity-study-2/ 2018-10-18T20:51:18+00:00 https://soundpharma.com/sound-pharmaceuticals-advances-phase-2-hearing-loss-clinical-trial-in-cystic-fibrosis-2/ 2019-01-14T17:27:23+00:00 https://soundpharma.com/soundpharma-com-sound-pharmaceuticals-announces-positive-topline-results-from-spi-1005-phase-2b-menieres-disease-clinical-trial/ 2019-07-08T17:41:50+00:00 https://soundpharma.com/sound-pharmaceuticals-announces-completion-of-patient-enrollment-in-the-phase-2b-menieres-disease-clinical-trial/ 2019-07-08T17:52:04+00:00 https://soundpharma.com/fda-grants-fast-track-designation-for-spi-1005-in-the-treatment-of-menieres-disease/ 2020-01-03T17:46:46+00:00 https://soundpharma.com/university-of-oxford-and-sound-pharmaceuticals-complete-phase-2-bipolar-disorder-study-with-spi-1005/ 2020-08-03T21:58:39+00:00 https://soundpharma.com/sound-pharmaceuticals-advances-pivotal-phase-3-clinical-trials-in-menieres-disease/ 2020-08-03T22:07:16+00:00 https://soundpharma.com/sound-pharmaceuticals-files-ind-to-test-spi-1005-in-phase-2-covid-19-trials/ 2020-08-03T22:10:15+00:00 https://soundpharma.com/fda-allows-sound-pharmaceuticals-to-test-spi-1005-as-a-novel-treatment-for-covid-19/ 2020-08-31T21:27:48+00:00 https://soundpharma.com/3-1m-nih-grant-to-test-spi-1005-in-covid-19/ 2022-04-20T21:12:43+00:00 https://soundpharma.com/clinical-research-associate/ 2022-05-04T17:51:29+00:00 https://soundpharma.com/sound-pharmaceuticals-nih-grant-for-a-novel-oral-covid-19-treatment-increases-to-4-2m/ 2022-05-11T23:53:49+00:00 https://soundpharma.com/sound-pharmaceuticals-initiates-enrollment-in-pivotal-phase-3/ 2022-07-28T16:43:56+00:00 https://soundpharma.com/sound-pharma-completes-enrollment-in-pivotal-phase-3-clinical-trial-of-spi-1005-for-treatment-md-hearing-loss-tinnitus-dizziness/ 2023-05-03T17:58:58+00:00 https://soundpharma.com/sound-pharma-to-present-positive-interim-data-from-its-phase-2b-cystic-fibrosis-stop-ototoxicity-trial/ 2024-01-30T21:18:25+00:00 https://soundpharma.com/sound-pharmaceuticals-ind-involving-cochlear-implantation-allowed-by-the-fda/ 2024-05-23T01:00:15+00:00 https://soundpharma.com/sound-pharma-announces-phase-3-study-completion-of-spi-1005-for-the-treatment-of-menieres-disease/ 2024-07-31T16:31:02+00:00 https://soundpharma.com/sound-pharma-announces-positive-phase-3-results-for-the-treatment-of-menieres-disease-with-spi-1005/ 2024-12-10T21:50:25+00:00 https://soundpharma.com/sound-pharma-to-present-spi-1005-preclinical-and-clinical-hearing-loss-and-tinnitus-data-at-dhahces-and-aro-mwm/ 2025-07-08T17:47:08+00:00 https://soundpharma.com/sound-pharma-to-present-at-upcoming-life-sciences-industry-conferences/ 2025-07-08T17:47:44+00:00 https://soundpharma.com/fda-allows-sound-pharmaceuticals-to-begin-menieres-disease-clinical-trial/ 2025-10-06T16:05:21+00:00 https://soundpharma.com/sound-pharmaceuticals-and-university-of-oxford-to-collaborate-on-psychiatric-diseases/ 2025-10-06T16:05:34+00:00 https://soundpharma.com/sound-pharmaceuticals-announces-appointment-of-paul-rickey-as-chief-financial-officer/ 2025-10-06T16:05:43+00:00 https://soundpharma.com/sound-pharmaceuticals-announces-1-6-million-award-from-cystic-fibrosis-foundation-therapeutics-to-prevent-and-treat-the-hearing-loss-and-tinnitus-associated-with-antibiotic-use/ 2025-10-06T16:07:06+00:00 https://soundpharma.com/sound-pharmaceuticals-completes-enrollment-on-menieres-disease-clinical-trial-2/ 2025-10-06T16:07:27+00:00 https://soundpharma.com/enrollment-underway-in-cf-clinical-trial-for-ear-toxicity-caused-by-antibiotics/ 2025-10-06T16:07:50+00:00 https://soundpharma.com/sound-pharma-receives-fda-breakthrough-therapy-designation-for-spi-1005-to-treat-menieres-disease-2/ 2025-12-01T18:02:38+00:00 https://soundpharma.com/sound-pharma-completes-open-label-phase-3-for-spi-study-of-spi-1005-in-menieres-disease/ 2026-07-14T15:37:36+00:00